Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory conformance to the identity and strength of each active ingredient prior to release.
Inspection Record
PharMEDium Services LLC — FDA 483 Findings
Inspectors Russell GlapionThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed.
An adequate number of batches of each drug product are not tested to determine an appropriate expiration date.
Written procedures are lacking which describe in sufficient detail the receipt, identification, sampling, testing, and approval of closures.
Written records of investigation of a drug complaint do not include the findings of the investigation.
Each batch of drug product purporting to be sterile and pyrogen-free is not laboratory tested to determine conformance to such requirements.
Clothing of personnel engaged in the processing of drug products is not appropriate for the duties they perform.
About this record
Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
